Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
Biocon Biosimilar - Google News
Get the latest updates from Biocon Biosimilar - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated about 8 hours ago
EC approves Biocon Biologics’ denosumab biosimilars - The Pharma Letter
about 24 hours ago
EC approves Biocon Biologics’ denosumab biosimilars The Pharma Letter
Pegfilgrastim Biosimilars Market Exclusive Report with - openPR.com
1 day ago
Pegfilgrastim Biosimilars Market Exclusive Report with openPR.com
Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars - ET Now
2 days ago
Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars ET Now
Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars - ET Now
2 days ago
Biocon Biologics gets EU approval for Vevzuo and Evfraxy biosimilars ET Now
Insulin Biosimilars Market Exclusive Report with Detailed - openPR.com
2 days ago
Insulin Biosimilars Market Exclusive Report with Detailed openPR.com
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market - Life Sciences Intellectual Property Review
2 days ago
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market...
Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for bone - The Economic Times
2 days ago
Biocon biologics receives European Commission approval for Vevzuo, Evfraxy Denosumab biosimilars for...
Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars - PR Newswire UK
2 days ago
Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars PR Newswire...
Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars - PR Newswire
2 days ago
Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars PR Newswire
biocon biologics has received marketing authorisation in europe for vevuzo and evfraxy biosimilars - ICICI Direct
2 days ago
biocon biologics has received marketing authorisation in europe for vevuzo and evfraxy...
Biocon Biologics gets EU approval for 2 drugs to treat bone cancer, osteoporosis and bone loss - financialexpress.com
2 days ago
Biocon Biologics gets EU approval for 2 drugs to treat bone cancer...
Biocon arm gets market authorisation in EU for two biosimilars of Denosumab - CNBC TV18
2 days ago
Biocon arm gets market authorisation in EU for two biosimilars of Denosumab...